Novartis India Ltd's earnings have declined by -35%, whereas share price has appreciated 3.2% CAGR over the past five years, indicating the company’s share price is likely overvalued. However, for specific investment actions please consult your investment advisor.
Novartis India Ltd share price has declined -0.3% annually (CAGR) over the past ten years.
Past 10 years financial track record analysis and assessment of future prospects by Moneyworks4me indicates that Novartis India Ltd is an average long term investment. However, you need to ensure you buy at a right price to earn good returns.
Novartis has been in India since 1947. The Group operates in India through four entities namely Novartis India Limited, listed on the Mumbai Stock Exchange, Novartis Healthcare Private Limited, Sandoz Private Limited and Chiron-Behring Vaccine Private Limited. In India Novartis have a presence in pharmaceuticals, generics (pharmaceutical products that are off patent), Vaccines, OTC (over-the-counter medicines), eyecare and Animal Health.
Novartis was created in
Novartis was created in 1996 through the merger of Ciba-Geigy and Sandoz, two companies with a rich and diverse corporate history. Throughout the years, Novartis and its predecessor companies have discovered and developed many innovative products for patients and consumers worldwide.
Today, Novartis has 4 500 associates in India, 115 000 associates in 140 countries worldwide.
Novartis is a world leader in the research and development of products to protect and improve health and well-being. The company has core businesses in pharmaceuticals, vaccines, consumer health, generics, eye care and animal health.
Pharmaceuticals- Under this the company currently owns 45 key marketed products in therapeutic area. Novartis owns products like Diovan HCT, Gleevec, Lamisil, Zometa are amongst others.
Vaccines and Diagnostics- This division is a leader in providing products to fight more than 20 vaccine-preventable viral and bacterial diseases and blood-testing equipment. Currently the company owns vaccines for influenza meningitis, rabies, tick-borne encephalitis, haemophilus influenzae type b (hib), polio, diphtheria, tetanus and pertussis.
Sandoz- This is the generic pharmaceutical division of company catering its products to areas like antibiotics, treatments for central-nervous-system disorders, gastrointestinal medicines, cardiovascular treatments and hormone therapies.
Over-the-Counter- The Companyâ€™s over-the-counter (OTC) products cater in area of analgesics, cough, cold, allergy, gastrointestinal, skin care and smoking-cessation treatments, as well as mineral supplements.
Animal Health- The company provides products for preventing and treatment of several widespread animal diseases and parasite infestations. The majority of these products are available by prescription through veterinarians.
Novartis is also engaged in manufacturing of contact lenses and lens care products.